Future outperforming subsectors in pharma

Future outperforming subsectors in pharma

Oncology, immunology & neurology will outperform the overall pharmaceutical sector over the coming decade. Innovation will drive this out-performance. IQVIA estimates annual spending on oncology and immunology will reach US$ 273bn and US$ 175bn respectively, with over 100 new...

Continue reading →

A new era in cancer diagnosis

A new era in cancer diagnosis

Continue reading →

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Siemens Healthineers (SHL.DE) announced that it would acquire Varian Medical Systems (VAR) on the 2nd of August 2020 for USD 16.4bn. Siemens will purchase all of Varian's shares for $177.50/share in cash; a 24% premium. The deal will be financed...

Continue reading →